Hepatitis D laboratory tests

Revision as of 19:43, 16 March 2012 by Varun Kumar (talk | contribs)
Jump to navigation Jump to search

Hepatitis Main Page

Hepatitis D

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Hepatitis D from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Hepatitis D laboratory tests On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hepatitis D laboratory tests

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hepatitis D laboratory tests

CDC on Hepatitis D laboratory tests

Hepatitis D laboratory tests in the news

Blogs on Hepatitis D laboratory tests

Directions to Hospitals Treating Hepatitis D

Risk calculators and risk factors for Hepatitis D laboratory tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Varun Kumar, M.B.B.S. [2]

Lab Tests

  • Detection of HDV RNA using reverse transcriptase polymerase chain reaction assay has a high sensitivity in detection of HDV viremia.
  • HDV antigen may be detected.
  • Levels of anti-delta agent antibodies such as IgM and IgG are generally be elevated. Detection of IgA antibodies to HDV is exclusively associated with chronic HDV infection.[1]
  • Patients may also be positive for HBsAg and anti-HB core IgM. However HBsAg levels may be suppressed to undetectable levels with active HDV replication.
  • Liver function tests may generally show elevated serum alanine aminotransferase and aspartate aminotransferase levels.
  • Elevated international normalized ratio (INR) with prolongation of prothrombin time suggests fulminant hepatic failure.

References

  1. McFarlane IG, Chaggar K, Davies SE, Smith HM, Alexander GJ, Williams R (1991). "IgA class antibodies to hepatitis delta virus antigen in acute and chronic hepatitis delta virus infections". Hepatology (Baltimore, Md.). 14 (6): 980–4. PMID 1959886. Unknown parameter |month= ignored (help); |access-date= requires |url= (help)

Template:WH Template:WS